Facebook Linkedin RSS Twitter Youtube
Home 2022

Bladder cancer

New Cancer Immunotherapy Target: Male Sex Hormone?
Cancer

New Cancer Immunotherapy Target: Male Sex Hormone?

Improving the Chemo-Immunotherapy Response in Bladder Cancer
Cancer

Improving the Chemo-Immunotherapy Response in Bladder Cancer

Liquid Biopsy for Bladder Cancer Could Guide Immunotherapy Options
Cancer

Liquid Biopsy for Bladder Cancer Could Guide Immunotherapy Options

BridgeBio, Helsinn Ink Up-to-$2.4B Infigratinib Partnership
Cancer

BridgeBio, Helsinn Ink Up-to-$2.4B Infigratinib Partnership

Synthesized Tumor Cells Allow Scientists to Conduct Research More Efficiently
Cancer

Synthesized Tumor Cells Allow Scientists to Conduct Research More Efficiently

Team Gains Insights on How Bladder Cancer Is Linked to Smoking
Cancer

Team Gains Insights on How Bladder Cancer Is Linked to Smoking

Protein Biomarker Differentiates between Cystitis and Bladder Cancer
Cancer

Protein Biomarker Differentiates between Cystitis and Bladder Cancer

AFM and Machine Learning Combined to Noninvasively Diagnose Bladder Cancer
Cancer

AFM and Machine Learning Combined to Noninvasively Diagnose Bladder Cancer

Translational Platform for Immuno-Oncology Discovery
Drug Discovery

Translational Platform for Immuno-Oncology Discovery

Ferring Gains Option to FKD’s Phase III Bladder Cancer Gene Therapy Candidate
Cancer

Ferring Gains Option to FKD’s Phase III Bladder Cancer Gene Therapy Candidate

123...9Page 2 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.